Depression: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• BDNF 1
• NMDA 7
• NLRP3 0
• GLP-1 1
• TNF 0
• IL-6 3
• NRF2 0
• PPAR 0
• AMPK 0
• mTOR 0
• STAT3 0
• AKT 0
• JAK 1
• TLR4 0
• ERK 0
• IL-1 0
• PI3K 0
• AQP4 0
• HDAC 0
• HMGB1 0
• METTL3 0
• MMP-9 0
• SGLT2 0
• SIRT1 0
• VEGF 0
• BACE1 0
• C9orf72 0
• CCR5 0
• CD19 0
• CD22 0
• COX-2 0
• CTNNB1 0
• CXCR4 0
• DPP-4 0
• FOXP3 0
• HSP90 0
• IDO1 0
• IL-15 0
• IL-17 0
• IL-4 1
• MAPK 0
• MEK 0
• PARP 0
• PDGFR 0
• PINK1 0
• PRMT5 0
• RANKL 0
• SNCA 0
• STING 0
• TP53 0

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients

  NCT04410341· Sadat City University· Updated 14 Jul 2025

  “Institutional and funding constrains”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients

  NCT04410341· Sadat City University· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 14
• Mendelian Randomization Analysis 82
• CRISPR-Cas Systems 1
• Gene Expression Profiling 60
• Sequence Analysis, RNA 4
• Whole Genome Sequencing 1
• Exome Sequencing 4
• Proteomics 25
• Metabolomics 21
• Mass Spectrometry 2
• Flow Cytometry 1
• Immunohistochemistry 1
• Positron-Emission Tomography 25
• Magnetic Resonance Imaging 453
• Machine Learning 106
• Deep Learning 20
• Cohort Studies 125
• Genome-Wide Association Study 147

See which targets of this disease your abstract mentions, and go to the people working on them.